Tumor-Derived Extracellular Vesicles Require β1 Integrins to Promote Anchorage-Independent Growth
Tumor-Derived Extracellular Vesicles Require β1 Integrins to Promote Anchorage-Independent Growth
复制标题
DOI:
10.1016/j.isci.2019.03.022
复制
发表时间:
2019-04-26
期刊:
影响因子:
5.8
通讯作者:
Languino, Lucia R.
中科院分区:
文献类型:
--
作者:
DeRita, Rachel M.;Sayeed, Aejaz;Languino, Lucia R.
The beta 1 integrins, known to promote cancer progression, are abundant in extracellular vesicles (EVs). We investigated whether prostate cancer (PrCa) EVs affect anchorage-independent growth and whether beta 1 integrins are required for this effect. Specifically using a cell-line-based genetic rescue and an in vivo PrCa model, we show that gradient-purified small EVs (sEVs) from either cancer cells or blood from tumor-bearing TRAMP (transgenic adenocarcinoma of the mouse prostate) mice promote anchorage-independent growth of PrCa cells. In contrast, sEVs from cultured PrCa cells harboring a short hairpin RNA to beta 1, from wild-type mice or from TRAMP mice carrying a beta 1 conditional ablation in the prostatic epithelium (beta 1(Pc-/-)), do not. We find that sEVs, from cancer cells or TRAMP blood, are functional and co-express beta 1 and sEV markers; in contrast, sEVs from beta 1(Pc-/-)/TRAMP or wild-type mice lack beta 1 and sEV markers. Our results demonstrate that beta 1 integrins in tumor-cell-derived sEVs are required for stimulation of anchorage-independent growth.